Affinity Health Research Institute

Affinity Health Research Institute (AHRI) is a dedicated clinical research site based in Cypress, Texas, specializing in Phase II through IV clinical trials. The institute partners with global pharmaceutical companies and contract research organizations to evaluate new therapies across a broad spectrum of therapeutic areas, including endocrinology, cardiology, and respiratory medicine. AHRI is particularly recognized for its expertise in metabolic disorders such as Type 2 diabetes, obesity, and MASH (NASH). The facility provides comprehensive trial management, patient recruitment, and high-quality data collection to support the drug development process. By maintaining a focus on clinical excellence and patient safety, AHRI serves as a vital link in bringing innovative medical treatments to the market.